case_images: PMC10461182_01
case_images: Proportional gender distribution of AE reports across various age groups.
case_images: fphar-14-1208456-g001.jpg
case_images: PMC10461182_01_fphar-14-1208456-g001.jpg
case_images: F1
case_images: The distribution of AE reports across various age groups, along with the percentage representation of both genders within each age group, is depicted in Figure 1.
case_images: Positive signal distribution for methylphenidate, atomoxetine, and amphetamine using standardized MedDRA queries. Abbreviations: excl, excluding; MedDRA, Medical Dictionary for Regulatory Activiti; PRR, Proportional Reporting Ratio.
case_images: fphar-14-1208456-g002.jpg
case_images: PMC10461182_01_fphar-14-1208456-g002.jpg
case_images: F2
case_images: Detailed results are provided in Figure 2.
case_images: Positive signal distribution for methylphenidate, atomoxetine, and amphetamine using standardized MedDRA queries. Abbreviations: excl, excluding; MedDRA, Medical Dictionary for Regulatory Activiti; PRR, Proportional Reporting Ratio.
case_images: fphar-14-1208456-g003.jpg
case_images: PMC10461182_01_fphar-14-1208456-g003.jpg
case_images: F3
case_images: Detailed results are provided in Figure 3.
case_images: Signal strength for methylphenidate, atomoxetine, and amphetamine based on the PT level in FAERS. Abbreviations: FAERS, United States Food and Drug Administration Adverse Event Reporting System; PT, preferred term; SOC, System Organ Class.
case_images: fphar-14-1208456-g004.jpg
case_images: PMC10461182_01_fphar-14-1208456-g004.jpg
case_images: F4
case_images: Figure 4 illustrates the adverse reaction signals of the three drugs by different age groups, while Figure 5 demonstrates the adverse reaction signals by different genders among both child and adult patients.
case_images: Signal strength for methylphenidate, atomoxetine, and amphetamine based on the PT level in FAERS. Abbreviations: FAERS, United States Food and Drug Administration Adverse Event Reporting System; PT, preferred term; SOC, System Organ Class.
case_images: fphar-14-1208456-g005.jpg
case_images: PMC10461182_01_fphar-14-1208456-g005.jpg
case_images: F5
case_images: Figure 4 illustrates the adverse reaction signals of the three drugs by different age groups, while Figure 5 demonstrates the adverse reaction signals by different genders among both child and adult patients.